Registered entities
Complement Therapeutics Limited
Reg. No. 12515463United Kingdom
Innovation
8 patent families (2 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 1,099 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 6.5K social following, 6 posts in the last 12 months — above the industry median.
Investor mix
9 investors on record; lead investors include Gimv, Forbion.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 1 | 11% |
| Other / undisclosed | 3 | 33% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
9 Jun 2026 · Associate Clinical Trial Manager · White City, London
12 May 2026 · Clinical Trial Administrator · UK-based
Based on job postings tracked across public sources.
Recent activity
12 Jun 2026
Event
6th Annual CTS Retina 2026
9 Jun 2026
Event
CTx001 GA Clinical Trial Program: Novel Endpoints to Connect Structure and Function
24 Apr 2026
Event
Association for Research in Vision and Ophthalmology (ARVO)